Yeast expressed cytochrome P450 2D6 (CYP2D6) exposed on the external face of plasma membrane is functionally competent

被引:29
|
作者
Loeper, J [1 ]
Louérat-Oriou, B [1 ]
Duport, C [1 ]
Pompon, D [1 ]
机构
[1] Univ Paris 06, CNRS, Lab Propre Associe, Ctr Genet Mol, F-91198 Gif Sur Yvette, France
关键词
D O I
10.1124/mol.54.1.8
中图分类号
R9 [药学];
学科分类号
1007 ;
摘要
CYP2D6, a xenobiotic metabolizing cytochrome P450 (P450), was found to be present in significant amount on the outer face of cell plasma membrane in addition to the regular microsomal location. Present work demonstrates that this external P450 is catalytically competent and that activity is supported by NADPH-P450 reductase present on the inner face of plasma membrane. Purified plasma membranes from yeast expressing CYP2D6 sustained NADPH- and cumene hydroperoxide-dependent dextromethorphan demethylation and NADPH-cytochrome c activity confirming previous observations in human hepatocytes. CYP2D6 found on the outside of plasma membrane (by differential immune-inhibition and acidic shift assays on transformed spheroplasts) was catalytically competent at the cell surface for NADPH-supported activities. Anti-yeast P450-reductase antibodies inhibited neither CYP2D6 nor P450-reductase activities upon incubation with intact spheroplasts. In contrast, both activities were inhibited on isolated plasma membrane fragments. This highly suggested a cytosolic-orientation of the plasma membrane P450-reductase. This finding was confirmed by immunostaining in confocal microscopy. Finally, gene deletion of P450-reductase caused a complete loss of plasma membrane NADPH-supported CYP2D6 activity, which suggests that the reductase participates to some degree in the transmembrane electron transfer chain. This work illustrates that the outside-exposed plasma membrane CYP2D6 is active and may play an important metabolic role.
引用
收藏
页码:8 / 13
页数:6
相关论文
共 50 条
  • [41] Topology and functionality of reductase and P450 2D6 expressed in yeast microsomal and plasma membranes.
    Loeper, J
    Louérat-Oriou, B
    Pompon, D
    FASEB JOURNAL, 1997, 11 (09): : A788 - A788
  • [42] The endocannabinoid anandamide is a substrate of cytochrome P450 2D6
    Snider, Natasha Tasheva
    Sridar, Chitra
    Hollenberg, Paul
    FASEB JOURNAL, 2008, 22
  • [43] Oxidation of methoxytyramines by recombinant cytochrome P450 2D6
    Hanna, IH
    Nishimura, Y
    Miller, GP
    Rizzo, CJ
    Guengerich, FP
    FASEB JOURNAL, 2000, 14 (08): : A1335 - A1335
  • [44] Hot flushes, tamoxifen and cytochrome P450 2D6
    Boutet, G.
    ONCOLOGIE, 2012, 14 (6-7) : 357 - 364
  • [45] Cytochrome P450 2D6 genetic polymorphisms of ugandans
    Miura, I.
    Saito, K.
    Obua, C.
    Abbo, C.
    Kaneko, S.
    Tateishi, T.
    INTERNATIONAL JOURNAL OF NEUROPSYCHOPHARMACOLOGY, 2012, 15 : 103 - 103
  • [46] The role of cytochrome P450 2D6 in the metabolism of moclobemide
    Hartter, S
    Dingemanse, J
    Baier, D
    Ziegler, G
    Hiemke, C
    EUROPEAN NEUROPSYCHOPHARMACOLOGY, 1996, 6 (03) : 225 - 230
  • [47] Crystal structure of human cytochrome P450 2D6
    Rowland, P
    Blaney, FE
    Smyth, MG
    Jones, JJ
    Leydon, VR
    Oxbrow, AK
    Lewis, CJ
    Tennant, MG
    Modi, S
    Eggleston, DS
    Chenery, RJ
    Bridges, AM
    JOURNAL OF BIOLOGICAL CHEMISTRY, 2006, 281 (11) : 7614 - 7622
  • [48] Cytochrome P450 2D6 and treatment of codeine dependence
    Romach, MK
    Otton, SV
    Somer, G
    Tyndale, RF
    Sellers, EM
    JOURNAL OF CLINICAL PSYCHOPHARMACOLOGY, 2000, 20 (01) : 43 - 45
  • [49] Cytochrome P450 2D6 polymorphism and character traits
    Suzuki, E
    Kitao, Y
    Ono, Y
    Iijima, Y
    Inada, T
    PSYCHIATRIC GENETICS, 2003, 13 (02) : 111 - 113
  • [50] Duplication/ultrarapid metabolism of cytochrome P450 2D6 (CYP2D6) as possible cause for dextromethorphan (DM)/dextrorphan (DX) overdose in a child
    Lowry, J. A.
    Gaedigk, A.
    Pearce, R. E.
    Pierson, M. S.
    Leeder, J. S.
    CLINICAL TOXICOLOGY, 2008, 46 (07) : 609 - 610